Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06781437

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Studio Osservazionale Retrospettivo Di Coorte Italiana Di Pazienti Con Linfoma (RETRO-LYMPH)

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,500 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021

Detailed description

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021. Study objectives are to enrich the data on the prognostic role of clinical and epidemiological factors associated with clinical and epidemiological data of patients; * to identify the factors that affect the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment; * to provide a platform for future research projects; * Description of the various therapies that have occurred over time, duration of treatment, causes of interruption of treatment, responses; * Description of the adverse events / safety of the various therapies for lymphoma and lymphoproliferative syndromes; * Patient survival. Descriptive analyses will be conducted by tabulating frequency distributions and percentages and mean and median values, standard deviations, quartiles and extreme values for continuous variables. Progression-free survival, disease-free survival and overall survival will be examined using Kaplan-Meier point estimates

Conditions

Timeline

Start date
2022-02-01
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2025-01-17
Last updated
2025-01-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06781437. Inclusion in this directory is not an endorsement.